Pfizer (PFE) Shares Outstanding (2009 - 2026)

Pfizer (PFE) has 16 years of Shares Outstanding data on file, last reported at $9.6 billion in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $9.6 billion, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.6 billion (changed 0.22% YoY), and the FY2025 annual result was $9.6 billion, changed 0.29% from the prior year.
• Shares Outstanding was little changed at $9.6 billion in Q1 2026 per PFE's latest filing, from $9.6 billion in the prior quarter.
• Over five years, Shares Outstanding peaked at $9.6 billion in Q1 2026 and troughed at $9.5 billion in Q2 2022.
• A 5-year average of $9.6 billion and a median of $9.6 billion in 2024 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding climbed 0.7% in 2023, then grew 0.22% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $9.5 billion in 2022, then increased by 0.45% to $9.6 billion in 2023, then climbed by 0.32% to $9.6 billion in 2024, then climbed by 0.29% to $9.6 billion in 2025, then rose by 0.21% to $9.6 billion in 2026.
• Business Quant data shows PFE's Shares Outstanding at $9.6 billion in Q1 2026, $9.6 billion in Q4 2025, and $9.6 billion in Q3 2025.